329 related articles for article (PubMed ID: 31764070)
1. Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015.
Poizot-Martin I; Lions C; Cheret A; Rey D; Duvivier C; Jacomet C; Allavena C; Huleux T; Bani-Sadr F; Obry-Roguet V; Makinson A;
AIDS; 2020 Mar; 34(4):569-577. PubMed ID: 31764070
[TBL] [Abstract][Full Text] [Related]
2. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
[TBL] [Abstract][Full Text] [Related]
3. Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.
Lodi S; Guiguet M; Costagliola D; Fisher M; de Luca A; Porter K;
J Natl Cancer Inst; 2010 Jun; 102(11):784-92. PubMed ID: 20442214
[TBL] [Abstract][Full Text] [Related]
4. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
Sullivan SG; Hirsch HH; Franceschi S; Steffen I; Amari EB; Mueller NJ; Magouras I; Biggar RJ; Rickenbach M; Clifford GM;
AIDS; 2010 Sep; 24(14):2245-52. PubMed ID: 20543658
[TBL] [Abstract][Full Text] [Related]
5. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
[TBL] [Abstract][Full Text] [Related]
6. Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.
Nguyen HQ; Magaret AS; Kitahata MM; Van Rompaey SE; Wald A; Casper C
AIDS; 2008 May; 22(8):937-45. PubMed ID: 18453853
[TBL] [Abstract][Full Text] [Related]
7. Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy.
Lacombe JM; Boue F; Grabar S; Viget N; Gazaignes S; Lascaux-Cametz AS; Pacanowski J; Partisani M; Launay O; Matheron S; Rosenthal E; Rouveix E; Tattevin P; de Truchis P; Costagliola D; Goedert JJ
AIDS; 2013 Feb; 27(4):635-43. PubMed ID: 23196937
[TBL] [Abstract][Full Text] [Related]
8. A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma.
Semeere A; Wenger M; Busakhala N; Buziba N; Bwana M; Muyindike W; Amerson E; Maurer T; McCalmont T; LeBoit P; Musick B; Yiannoutsos C; Lukande R; Castelnuovo B; Laker-Oketta M; Kambugu A; Glidden D; Wools-Kaloustian K; Martin J
Cancer Med; 2016 May; 5(5):914-28. PubMed ID: 26823008
[TBL] [Abstract][Full Text] [Related]
9. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
[TBL] [Abstract][Full Text] [Related]
10. Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4
Freitas IT; Tinago W; Sawa H; McAndrews J; Doak B; Prior-Fuller C; Sheehan G; Lambert JS; Muldoon E; Cotter AG; Hall WW; Mallon PWG; Carr MJ
AIDS Res Ther; 2020 Apr; 17(1):13. PubMed ID: 32295609
[TBL] [Abstract][Full Text] [Related]
11. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
[TBL] [Abstract][Full Text] [Related]
12. Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review.
Charpentier C; Delyon J; Glotz D; Peraldi MN; Rerolle JP; Barrou B; Ducroux E; Coilly A; Legeai C; Barete S; Lebbé C
Transplantation; 2019 Jan; 103(1):e22-e28. PubMed ID: 30273235
[TBL] [Abstract][Full Text] [Related]
13. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
[TBL] [Abstract][Full Text] [Related]
14. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
15. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
16. Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015.
Poizot-Martin I; Obry-Roguet V; Duvivier C; Lions C; Huleux T; Jacomet C; Ferry T; Cheret A; Allavena C; Bani-Sadr F; Palich R; Cabié A; Fresard A; Pugliese P; Delobel P; Lamaury I; Hustache-Mathieu L; Brégigeon S; Makinson A; Rey D;
J Eur Acad Dermatol Venereol; 2020 May; 34(5):1065-1073. PubMed ID: 31953902
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
[TBL] [Abstract][Full Text] [Related]
18. CD4
Vivancos-Gallego MJ; Okhai H; Perez-Elías MJ; Gomez-Ayerbe C; Moreno-Zamora A; Casado JL; Quereda C; Sanz JM; Sanchez-Conde M; Serrano-Villar S; Del Campo S; Dronda F; Galan JC; Sabin CA; Moreno S
Antivir Ther; 2020; 25(2):91-100. PubMed ID: 32338638
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
Wang X; Xiao J; Zhang L; Liu Y; Chen N; Deng M; Song C; Liu T; Zhang Y; Zhao H
Chin Med J (Engl); 2023 Sep; 136(18):2168-2177. PubMed ID: 37580056
[TBL] [Abstract][Full Text] [Related]
20. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA;
J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
